Roles of CD40/CD40 ligand molecules in human immunological disorders
CD40/CD40配体分子在人类免疫疾病中的作用
基本信息
- 批准号:11670745
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1) Characterization of human CD40 ligand deficiency : 35 x-linked hyper IgM syndrome (XHIM) patients were newly identified and their correlation of CD40 ligand mutation and the clinical phenotypes was examined. Screening methods of CD40 ligand deficiency using SSCP and ELISA that measures sCD40 ligand have been established. Carriers of XHIM were found to have decreased amounts of sCD40 ligand and all patients had non-detectable levels of sCD40 ligand.2) Characterization of hyper IGM syndrome type 2 : Nine Japanese patients with hyper IgM syndrome type 2 were characterized. All patients had mutations in AID. Seven patients were from non-consanguineous families, and six of them had a missense mutation in the same codon, suggesting that this codon is the hot spot of AID mutation. In all patients, IgG, IgA and IgE levels in the sera were undetectable, and somatic hyper mutations were impaired in their peripheral blood B cells. B cells failed to produce detectable amounts of IgE if cultured with anti-CD40 and IL-4. These results indicate that AID plays indispensable roles in class switch and somatic hypermutation in human B cells.3) Roles of Ku in the signaling pathway of CD40 : Ku was identified as the molecule that is involved in the CD40 signaling, we found that Ku associates with intracytoplasmic region of CD40, and CD40 stimulation induces tyrosine phosphorylation of Ku. In addition, CD40 stimulation induces DNA-PK activity in B cells by Ku dependent fashion.
1)人CD 40配体缺陷的特征:35例新发现的X连锁高IgM综合征(XHIM)患者,并检查其CD 40配体突变与临床表型的相关性。用SSCP和ELISA检测sCD 40配体,建立了CD 40配体缺陷的筛查方法。发现XHIM的携带者具有减少的sCD 40配体的量,并且所有患者具有不可检测的sCD 40配体水平。2)高IgM综合征2型的表征:9名患有高IgM综合征2型的日本患者被表征。所有患者都有AID突变。7例患者均来自非血缘家系,其中6例在同一密码子上发生错义突变,提示该密码子是AID突变的热点。在所有患者中,血清中的IgG、伊加和IgE水平均检测不到,外周血B细胞中的体细胞超突变受损。如果用抗-CD 40和IL-4培养,B细胞不能产生可检测量的IgE。这些结果表明AID在人B细胞的类转换和体细胞超突变中起着不可或缺的作用。3)Ku在CD 40信号通路中的作用:Ku被鉴定为参与CD 40信号通路的分子,我们发现Ku与CD 40的胞浆内区域相关联,CD 40刺激可诱导Ku的酪氨酸磷酸化。此外,CD 40刺激通过Ku依赖性方式诱导B细胞中的DNA-PK活性。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nagasawa M. Imai M. Imai K. Itoh S. Kajiwara M. MorioT. Nonoyama S.: "In vivo class switch of B cells after cord blood stem cell transplantation in severe combined immune deficient (SCID) patient"American J. Hematol.. 65. 176-177 (2000)
长泽 M. 今井 M. 今井 K. 伊藤 S. Kajiwara M. MorioT。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nagasawa M.,Imai M.,Imai K.,Itoh S.,Kajiwara M.,Morio T.,Nonoyama S.: "In vivo class switch of B cells after cord blood stem cell transplantation in severe combined immune deficient (SCID) patient."American J.Homatol.. 65. 176-177 (2000)
Nagasawa M.,Imai M.,Imai K.,Itoh S.,Kajiwara M.,Morio T.,Nonoyama S.:“严重联合免疫缺陷(SCID)脐带血干细胞移植后 B 细胞的体内类别转换
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Jo,EK.Hirokazu K.,Nonoyama S., et al.: "Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's Tyrosine Kinase (Btk) gene from seven Korean X-linked agammaglobulinemia (XLA) families."J.Immunol.. (in press). (2
Jo、EK.Hirokazu K.、Nonoyama S. 等人:“来自七个韩国 X 连锁无丙种球蛋白血症 (XLA) 家族的布鲁顿酪氨酸激酶 (Btk) 基因的突变特征,包括第一个内含子中的新调控缺陷
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kajiwara,M.,S.Nonoyama.: "WASP is involved in proliferation and differentiation of human haematopoietic progenitors in vitro"Br.J.Haematol.. 107. 254-262 (1999)
Kajiwara,M.,S.Nonoyama.:“WASP 参与体外人类造血祖细胞的增殖和分化”Br.J.Haematol.. 107. 254-262 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mori,M.,S.Nonoyama,M.Neubauer, et al: "Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia."J.Pediatr.Hematol./Oncol.. 22. 288-289 (2000)
Mori,M.,S.Nonoyama,M.Neubauer 等人:“慢性中性粒细胞减少症高免疫球蛋白 M 综合征病例中粒细胞集落刺激因子的突变分析和治疗反应。”J.Pediatr.Hematol./Oncol..
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NONOYAMA Shigeaki其他文献
NONOYAMA Shigeaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NONOYAMA Shigeaki', 18)}}的其他基金
Identification of novel differentiation factors in immune system using iPS cells derived from primary immunodeficiencies.
使用源自原发性免疫缺陷的 iPS 细胞鉴定免疫系统中的新型分化因子。
- 批准号:
26293250 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification and functional analysis of the genes critical for B cell terminal differentiation in ICF syndrome.
ICF 综合征中 B 细胞终末分化关键基因的鉴定和功能分析。
- 批准号:
25670484 - 财政年份:2013
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Research for developing of a screening method for the congenital immunodeficiency by KREC/TREC to apply the method to the pathologic analysis
KREC/TREC 开发先天性免疫缺陷筛查方法并应用于病理分析的研究
- 批准号:
22390213 - 财政年份:2010
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of expression mechanism of FcepsilonRI on human mast cells.
FcepsilonRI在人肥大细胞上的表达机制分析。
- 批准号:
08670860 - 财政年份:1996
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
CD40 ligand 转基因B淋巴瘤细胞来源exosome的抗肿瘤作用
- 批准号:81071948
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:面上项目
相似海外基金
Development of innovative treatment targeted for CD40 ligand for patients with multiple sclerosis
开发针对多发性硬化症患者的 CD40 配体创新疗法
- 批准号:
17K16109 - 财政年份:2017
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The Effects of CD40 Ligand Deficiency on Vascular Dysfunction, Immunoglobulin Production and Lymph Capillary Density in a Murine Model for High-Salt Diet
CD40 配体缺陷对高盐饮食小鼠模型中血管功能障碍、免疫球蛋白产生和毛细淋巴管密度的影响
- 批准号:
290587856 - 财政年份:2015
- 资助金额:
$ 2.5万 - 项目类别:
Research Fellowships
Ovarian cancer therapy using CD40 Ligand (CD40L)
使用 CD40 配体 (CD40L) 治疗卵巢癌
- 批准号:
8648384 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
Development of a multimeric CD40 ligand vaccine adjuvant
多聚体CD40配体疫苗佐剂的开发
- 批准号:
8456940 - 财政年份:2013
- 资助金额:
$ 2.5万 - 项目类别:
Development of a multimeric CD40 ligand vaccine adjuvant
多聚体CD40配体疫苗佐剂的开发
- 批准号:
8715683 - 财政年份:2013
- 资助金额:
$ 2.5万 - 项目类别:
Deciphering the role of CD40/CD40 ligand interaction in germinal center development using multiphoton intravital microscopy
使用多光子活体显微镜解读 CD40/CD40 配体相互作用在生发中心发育中的作用
- 批准号:
269571 - 财政年份:2012
- 资助金额:
$ 2.5万 - 项目类别:
Fellowship Programs
CD40 LIGAND AS ADJUVANT FOR RAISING PROTECTIVE ANTI-HIV AB BY DNA/MVA VACCINES
CD40 配体作为 DNA/MVA 疫苗产生保护性抗 HIV AB 的佐剂
- 批准号:
7715809 - 财政年份:2008
- 资助金额:
$ 2.5万 - 项目类别:
Establishment of diagnostic method of causative drug by detection of CD40 ligand expression in acute stage of drug eruption
药疹急性期CD40配体表达检测药物诊断方法的建立
- 批准号:
19790776 - 财政年份:2007
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
CD40 LIGAND AS ADJUVANT FOR RAISING PROTECTIVE ANTI-HIV AB BY DNA/MVA VACCINES
CD40 配体作为 DNA/MVA 疫苗产生保护性抗 HIV AB 的佐剂
- 批准号:
7562678 - 财政年份:2007
- 资助金额:
$ 2.5万 - 项目类别:
Immunotherapy of CLL with lentiviral expressed CD40-ligand
使用慢病毒表达的 CD40 配体进行 CLL 免疫治疗
- 批准号:
7161658 - 财政年份:2006
- 资助金额:
$ 2.5万 - 项目类别: